UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 60

Sortiert nach

Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer

International journal of radiation oncology, biology, physics, 2018-10, Vol.102 (2), p.287-295

2018

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Planned Treatment Breaks During Radiation Therapy for Anal Cancer: Update of RTOG 92-08

International journal of radiation oncology, biology, physics, 2008-09, Vol.72 (1), p.114-118

2008

Link zum Volltext

Verfügbarkeit prüfen

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions

International journal of radiation oncology, biology, physics, 1998-06, Vol.41 (3), p.501-510

1998

Link zum Volltext

Verfügbarkeit prüfen

Patterns and fate of PSA bouncing following 3D-CRT

International journal of radiation oncology, biology, physics, 2001-07, Vol.50 (4), p.845-849

2001

Link zum Volltext

Verfügbarkeit prüfen

A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer

International journal of radiation oncology, biology, physics, 1999-03, Vol.43 (4), p.719-725

1999

Link zum Volltext

Verfügbarkeit prüfen

Hypoxic regions exist in human prostate carcinoma

Urology (Ridgewood, N.J.), 1999, Vol.53 (1), p.11-18

1999

Link zum Volltext

Verfügbarkeit prüfen

Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas

Journal of gastrointestinal surgery, 2001-03, Vol.5 (2), p.121-130

2001

Link zum Volltext

Verfügbarkeit prüfen

Validation of a treatment policy for patients with prostate specific antigen failure after three‐dimensional conformal prostate radiation therapy

Cancer, 2003-02, Vol.97 (4), p.1127-1133

2003

Link zum Volltext

Verfügbarkeit prüfen

Defining the optimal radiation dose with three‐dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques

Cancer, 2001-09, Vol.92 (5), p.1281-1287

2001

Link zum Volltext

Verfügbarkeit prüfen

Late morbidity profiles in prostate cancer patients treated to 79–84 Gy by a simple four-field coplanar beam arrangement

International journal of radiation oncology, biology, physics, 2003, Vol.55 (1), p.71-77

2003

Link zum Volltext

Verfügbarkeit prüfen

Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy

The cancer journal from Scientific American, 1999-05, Vol.5 (3), p.152

1999

Link zum Volltext

Verfügbarkeit prüfen

Defining the appropriate radiation dose for pretreatment PSA ≤ 10 ng/mL prostate cancer

International journal of radiation oncology, biology, physics, 2000-06, Vol.47 (3), p.649-654

2000

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia in human prostate carcinoma : An Eppendorf PO2 study

American journal of clinical oncology, 2001-10, Vol.24 (5), p.458-461

2001

Link zum Volltext

Verfügbarkeit prüfen

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digital rectal examination

Urology (Ridgewood, N.J.), 2003-04, Vol.61 (4), p.754-759

2003

Link zum Volltext

Verfügbarkeit prüfen

PO29: Multi-Center Investigation of Inter-Observer Variability of a Novel Mobile CBCT Ring for Gynecological Cancer HDR Brachytherapy

Brachytherapy, 2023-09, Vol.22 (5), p.S79-S79

2023

Link zum Volltext

Verfügbarkeit prüfen

PO29

Brachytherapy, 2023-09, Vol.22 (5), p.S79

2023

Link zum Volltext

Verfügbarkeit prüfen

Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer

Urology (Ridgewood, N.J.), 2001-10, Vol.58 (4), p.614-618

2001

Link zum Volltext

Verfügbarkeit prüfen

Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer

Urology (Ridgewood, N.J.), 1999-07, Vol.54 (1), p.178-182

1999

Link zum Volltext

Verfügbarkeit prüfen

Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery method

International journal of radiation oncology, biology, physics, 2002-05, Vol.53 (1), p.236-243

2002

Link zum Volltext

Verfügbarkeit prüfen

Abstract LB-240: Circulating tumor cell (CTC) analysis in NRG oncology/RTOG 1014, repeat breast conserving treatment after in-breast recurrence (IBR)

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.LB-240-LB-240

2017

Link zum Volltext

Verfügbarkeit prüfen

Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control

International journal of radiation oncology, biology, physics, 2002-03, Vol.52 (4), p.888-892

2002

Link zum Volltext

Verfügbarkeit prüfen

Psychoeducational group intervention for wives of men with prostate cancer

Psycho-oncology (Chichester, England), 2004-01, Vol.13 (1), p.37-46

2004

Link zum Volltext

Verfügbarkeit prüfen

Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants

Radiotherapy and oncology, 2003-02, Vol.66 (2), p.173-179

2003

Link zum Volltext

Verfügbarkeit prüfen

Biochemical failure rates in prostate cancer patients predicted to have biologically insignificant tumors treated with three-dimensional conformal radiation therapy

International journal of radiation oncology, biology, physics, 2002-06, Vol.53 (2), p.277-281

2002

Link zum Volltext

Verfügbarkeit prüfen

NCOG-02. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi137-vi138

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 60

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(59)
Tagungsberichte
(1)

Sprache

Englisch
(60)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(40)
Male
(38)
Life Sciences & Biomedicine
(36)
Science & Technology
(36)
Biological And Medical Sciences
(26)
Medical Sciences
(26)
Aged
(25)
Middle Aged
(25)
Oncology
(25)
Prostatic Neoplasms - Radiotherapy
(25)
Prostatic Neoplasms - Pathology
(16)
Radiology, Nuclear Medicine & Medical Imaging
(16)
Nephrology. Urinary Tract Diseases
(15)
Tumors Of The Urinary System
(15)
Urinary Tract. Prostate Gland
(15)
Prostate-Specific Antigen - Blood
(14)
Prostatic Neoplasms - Blood
(14)
Adult
(13)
Neoplasm Staging
(12)
Radiotherapy Dosage
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer

Evaluation of Planned Treatment Breaks During Radiation Therapy for Anal Cancer: Update of RTOG 92-08

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions

Patterns and fate of PSA bouncing following 3D-CRT

A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer

Hypoxic regions exist in human prostate carcinoma

Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas

Validation of a treatment policy for patients with prostate specific antigen failure after three‐dimensional conformal prostate radiation therapy

Defining the optimal radiation dose with three‐dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques

Late morbidity profiles in prostate cancer patients treated to 79–84 Gy by a simple four-field coplanar beam arrangement

Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy

Defining the appropriate radiation dose for pretreatment PSA ≤ 10 ng/mL prostate cancer

Hypoxia in human prostate carcinoma : An Eppendorf PO2 study

Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digital rectal examination

PO29: Multi-Center Investigation of Inter-Observer Variability of a Novel Mobile CBCT Ring for Gynecological Cancer HDR Brachytherapy

PO29

Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer

Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer

Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery method

Abstract LB-240: Circulating tumor cell (CTC) analysis in NRG oncology/RTOG 1014, repeat breast conserving treatment after in-breast recurrence (IBR)

Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control

Psychoeducational group intervention for wives of men with prostate cancer

Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants

Biochemical failure rates in prostate cancer patients predicted to have biologically insignificant tumors treated with three-dimensional conformal radiation therapy

NCOG-02. PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933

Suchergebnisse filtern